- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Lupin Diagnostics unveils new Regional Reference Laboratory in Hyderabad
Hyderabad: Global pharma major Lupin Limited announced today the launch of its new Regional Reference Laboratory in Hyderabad, Telangana.
"This expansion of Lupin Diagnostics’ network is part of the company’s strategy to build and strengthen its presence in South India. Through the launch of this laboratory, Lupin Diagnostics will deliver high-quality and reliable diagnostic services to patients and consumers across Hyderabad and neighbouring cities," the company stated in its recent release.
This regional reference laboratory adds to Lupin Diagnostics’ existing network of 380+ LupiMitra collection centers and 23 laboratories across India. In addition to routine and specialized tests, Lupin Diagnostics offers molecular diagnostics, cytogenetics, flow cytometry, cytology, microbiology, serology, haematology, immunology, routine biochemistry and many more.
Read also: Lupin bags USFDA nod for Dolutegravir, Rilpivirine tablets to treat HIV infection
“We are thrilled to continue our mission of providing accessible and affordable quality healthcare to individuals and families in India,” said Ravindra Kumar, CEO, Lupin Diagnostics.
“Diagnostics test results are crucial for doctors and patients to make informed decisions. Accurate diagnosis is the first step towards managing diseases and identifying the appropriate line of treatment. Our personalized and interactive smart reports can help doctors and patients analyse historical patterns in health parameters and guide treatment options based on evidence,” he added.
Lupin Diagnostics Limited is a wholly owned subsidiary of Lupin Limited. Founded in October 2021, the company is headquartered in Mumbai, India and provides a comprehensive range of diagnostic services to doctors, patients, and consumers. The company offers several consumer-centric features, such as live home collection booking and tracking, GPS-enabled temperature-controlled sample movement, free home collection, NABL accreditation of each laboratory, smart reports, and trend report analysis.
Read also: Lupin Diagnostics launches Regional Reference Laboratory in Indore
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751